Back to CVE records
Medium 5.3Published Apr 15, 2026

CVE-2026-20152A vulnerability in the authentication service feature of Cisco AsyncOS Software for Cisco Secure Web Appliance could allow an unauthenticated, remote attacker to bypass authentication policy requirem…

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

A vulnerability in the authentication service feature of Cisco AsyncOS Software for Cisco Secure Web Appliance could allow an unauthenticated, remote attacker to bypass authentication policy requirements. This vulnerability is due to improper validation of user-supplied authentication input in HTTP requests. An attacker could exploit this vulnerability by sending HTTP requests that contain specific authentication requests to an affected device. A successful exploit could allow the attacker to bypass policy enforcement on the device. There is no direct impact to the Cisco Secure Web Appliance. However, as a result of exploiting this vulnerability, an attacker could send HTTP requests that should be restricted through the device.

CVSS
5.3 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness (CWE)
CWE-305
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Awaiting Analysis
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.